Business
ISG Event to Explore How Enterprises Are Delivering Strategic Value From AI
ISG Event to Explore How Enterprises Are Delivering Strategic Value From AI
About this update from Information Services Group, Inc.
[{"type":"text","content":"\nDraftKings, State Street, Pfizer, New York Life, Novartis, CVS Health, Bank of America, National Grid and SharkNinja will join ISG AI Impact Summit in Boston\n\n\n STAMFORD, Conn.--(BUSINESS WIRE)--\nInformation Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, will welcome enterprise leaders to the 2026 ISG AI Impact Summit to share strategies for delivering measurable, sustainable business value from AI initiatives.\n\n\nLeaders from DraftKings, State Street, Pfizer, New York Life Insurance Company, Novartis, CVS Health, Bank of America, National Grid, SharkNinja and more will join the event, June 2 – 3 at the Wyndham Boston Beacon Hill. The summit agenda will focus on strategies for realizing value from AI and overcoming the challenges of fragmented operating models, inadequate governance and data architectures and unclear accountability for humans and AI systems.\n\n\n“Organizations are confronting deeper operational questions around accountability, governance, ROI and infrastructure readiness, as AI evolves from a productivity tool into an autonomous operating layer,” said Loren Absher, director and Americas lead, ISG AI Advisory, and host of the ISG AI Impact Summit Boston. “The next phase of enterprise AI is about redesigning how business gets done.”\n\n\nOn the first day of the summit, Brian Walker, senior vice president of AI and Operations at DraftKings, will deliver a keynote session, “Building the AI-Native Operation: Lessons From Inside DraftKings,” on how AI is reshaping engineering, product and operational workflows, offering insights on how to decide whether to build, buy or partner for AI at scale.\n\n\nThe “Closing the AI ROI Gap: Why Investment is Outpacing Impact” panel discussion will feature Barbara Widholm, vice president, emerging technologies, State Street; Vivek Mukhatyar, GenAI medical engagement lead, Pfizer, and Abhishek Kumar, corporate vice president, New York Life Insurance Company, discussing the widening disconnect between AI spending and measurable business outcomes, including challenges related to governance, value attribution and scaling AI adoption.\n\n\nScott Bradley, vice president, AI & Innovation, Novartis; Radha Kuchibhotla, lead director, AI solutions design, CVS Health, and Maharaj Mukherjee, senior AI architect and senior vice president...